Hepatitis C

General Articles and Commentaries

• The Promise of a Cure: Why Are We Still Failing People with HCV? by Travis Manint HIV/HCV Watch

• CDC Recommends Single-Visit Hepatitis C Testing by Emily Harris JAMA July 26, 2023

• Analysis: Biden’s Budget Request Emphasizes HIV, HCV Goals by Jen Laws HIV/ HCV Update

• Biden wants to cure hepatitis C by 2030. These barriers have been standing in the way by PBS

• 2023 Poses Threats and Promises for Public Policy and Patient Advocates by Jen Laws HIV/HCV Update

• Blame Payers for Only 1:3 Patients Receiving HCV Cure by Jen Laws HIV/HCV Watch

• DOJ Complaint Flags HCV Drug Denials for People With Addiction by Megan Brooks Medscape

• Vertical hepatitis C transmission more common than assumed, study finds by Caitlyn Stulpin infectious Disease News

• Sadly Predictable: STIs & HCV Rates Rising Again by Jen Laws HIV/HCV Watch

• Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature

• Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature

• Fourth Annual State of HCV Care National Survey™ by HealthHCV

Medical Journal Articles

• Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain by Pablo Ryan, PhD; Jorge Valencia, PhD; Daniel Sepúlveda-Crespo, PhD: et al JAMA October 25, 2024

• Hepatitis C in Black Individuals in the USA Review by Oluwaseun Falade-Nwulia, MBBS, MPH. Sharon M. Kelly, PhD, Sasraku Amanor-Boadu, MD, MPH; et al JAMA November 9, 2o23

• A National Hepatitis C Elimination Program in the United States. A Historic Opportunity by Rachael L. Fleurence, MSc, PhD and Francis S. Collins, MD, PhD JAMA March 9, 2023

• Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C by Jennifer Abbasi JAMA March 9, 2023

• Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study by Polaris Observatory HCV Collaborators Lancet Gastroenterol Hepatol 2022 May;7(5):396-415.

• Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis by Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al Lancet Gastroenterol Hepatol. 2022 May;7(5):426-445.

• A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial by Sunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton. et al Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317

• Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. by Butt AA, Kanwal F. Clin Infect Dis. 2012 Jan 1;54(1):96-104

• Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver Zuckerman E, Safadi R, Oren R, et al Israeli Association for the Study of the Liver.Harefuah. 2012 Dec;151(12):709-14, 719.